Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celart
05-22
04-18
04-10
03-21
Proyek Keuangan Rantai Pasokan Emas Grosir RWA Web3 Pertama di Dunia – IGE Siap Diluncurkan dalam Waktu Dekat
AB Charity Foundation Launches to Pioneer a New Global Model for Public Good Driven by Institutional Trust and Technology
Follow the right strategy, ten times is not a dream: SeaGull EXchange accelerates returns
The Anniversary Celebration of Hong Kong Fengsuitang Came to a Successful Conclusion, and Thousands of Love Lunch Boxes Illuminated the Road of Charity
Hongsheng International Group: Berbasis Inovasi, Merintis Cetak Biru Baru untuk Industri Olahraga dan Hiburan Global
Global Times: Translators’ Voices: CPC’s efforts to improve conduct set example for Global South to safeguard people’s interests, enhance governance
©hak cipta2009-2020 Berita Hansen Mobile Games